Dr. Shih is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4220 Harding Pike
SE Building Suite 200
Nashville, TN 37205Phone+1 615-385-3751Fax+1 615-269-7085
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2000 - 2003
Vanderbilt University Medical CenterResidency, Internal Medicine, 1997 - 2000
Vanderbilt University School of MedicineClass of 1997
Certifications & Licensure
TN State Medical License 1998 - 2026
LA State Medical License 2003 - 2007
MD State Medical License 2000 - 2003
Clinical Trials
- Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma Start of enrollment: 2011 Oct 01
- MEK162 for Patients With RAS/RAF/MEK Activated Tumors Start of enrollment: 2013 Oct 10
- Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- 222 citationsUpdated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical tr...Howard L. Kaufman, Jeffery S. Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden
Journal for Immunotherapy of Cancer. 2018-01-19 - 872 citationsAvelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trialHoward L. Kaufman, Jeffery S. Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden
The Lancet. Oncology. 2016-10-01 - 74 citationsA phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumorsJohanna C. Bendell, Carla Kurkjian, Jeffrey R. Infante, Todd M. Bauer, Howard A. Burris
Investigational New Drugs. 2015-02-25
Journal Articles
- Randomized Phase II Study of Akt Blockade with or Without Ipatasertib in Abiraterone-Treated Patients with Metastatic Prostate Cancer with and Without PTEN LossKent Shih, MD, Clinical Cancer Research
- A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced MalignanciesKent C Shih, Kyriakos P Papadopoulos, Drew W Rasco, Clinical Cancer Research
Press Mentions
- Brain Tumor Survivor Celebrates Birthday Virtually with Doctors Who Saved His LifeMarch 22nd, 2021
BeiGene Announces Preliminary Clinical Data on PARP Inhibitor Pamiparib Presented at Annual Scientific Meeting and Education Day of the Society for Neuro-OncologyNovember 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
